Idea Exchange Meeting with Helen Evans (GAVI Alliance CEO), Suzuki Shigeharu (Chairman of Daiwa Securities Group), and HGPI
date : 6/3/2011
Although Febuarys Global Health Forum had a very broad theme, it was agreed that Japan will continue to confront global health issues using public funds and market mechanisms that use private funds. It was widely agreed that the significance of private funding needs to be expanded.
Since 2008, a total of 15 billion dollars in vaccine bonds was purchased by Japanese citizens, which supported many GAVI alliance activities. Arranged by Daiwa, vaccine bonds are issued by The International Finance Facility for Immunization Company (IFFIm). IFFIm raises funds in the international capital markets that are used by the GAVI Alliance to save children’s lives and protect people’s health by increasing access to immunization in developing countries.
Evans commenced the meeting by expression her gratitude to the Japanese for their cooperation with The GAVI Alliance. Japanese citizens have proven, and can continue to prove, the importance of their participation in innovative financial mechanisms like the vaccine bonds. In the future, GAVI Alliance, alongside Japanese businesses and think tanks, hopes to further validate the importance of strong cooperation.
Top Research & Recommendations Posts
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Policy Recommendations] Building a Research and Development System Together With People Living with Dementia and Their Families to Drive Parallel Progress in Creating an Inclusive Society and Advancing R&D (April 25, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Recommendations] Recommendations for the G7 Hiroshima Summit in 2023 Necessary Actions for AMR Control, Starting with the Introduction of Pull Incentives (August 29, 2022)
- [Policy Recommendations] Recommendations for the G7 Hiroshima Summit by the C7 Global Health Working Group (April 20, 2023)
- [Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Policy Recommendations] Requests for the G7 Hiroshima Summit and Related Ministerial Meetings: Promoting Measures for Climate Change and Planetary Health That Keep Pace With the International Community (December 19, 2022)
[Event Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders’ Declaration (April 28, 2023)
[Event Report] (Live Broadcasting) A Dementia Symposium Commemorating the G7 Health Ministers’ Meeting in Nagasaki “Collaboration in the International Community for Advancing Dementia Measures in a New Era” (May 14, 2023)
[Event Report] A NAGASAKI Planetary Health Expert Meeting “From COP27 and COP15 to the G7 Hiroshima Summit: New Partnerships for Solving Climate, Environment, Biodiversity and Health Issues” (May 12, 2023)
[RegistrationOpen] Health Policy Academy the 12th Session
[Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)